LIBTAYO 350 mg concentrate for solution for infusion., M1774, M1774, M1774
MS201924_0022
Phase 2 small_molecule active
Quick answer
LIBTAYO 350 mg concentrate for solution for infusion., M1774, M1774, M1774 for Non-Squamous Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Non-Squamous Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active